- Patent Title: Anti-CD20 antibodies and fusion proteins thereof and methods of use
-
Application No.: US10366709Application Date: 2003-02-14
-
Publication No.: US07151164B2Publication Date: 2006-12-19
- Inventor: Hans Hansen , Zhengxing Qu , David M. Goldenberg
- Applicant: Hans Hansen , Zhengxing Qu , David M. Goldenberg
- Applicant Address: US NJ Morris Plains
- Assignee: Immunomedics, Inc.
- Current Assignee: Immunomedics, Inc.
- Current Assignee Address: US NJ Morris Plains
- Agency: Rossi, Kimms & McDowell LLP
- Main IPC: C12P21/08
- IPC: C12P21/08 ; C07H21/04 ; A61K39/395 ; C12N15/00 ; C07K16/00 ; C07H21/02 ; G01N33/574 ; A61K49/00
Abstract:
The present invention provides humanized, chimeric and human anti-CD20 antibodies and CD 20 antibody fusion proteins that bind to a human B cell marker, referred to as CD20, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies and autoimmune diseases, and methods of treatment and diagnosis.
Public/Granted literature
- US20030219433A1 Anti-CD20 antibodies and fusion proteins thereof and methods of use Public/Granted day:2003-11-27
Information query
